|
|
Post by #NoMoreNeedles on Jan 17, 2019 11:36:21 GMT -5
|
|
|
|
Post by matt on Jan 17, 2019 12:07:03 GMT -5
What is interesting is a comparison of the two curves using 12 month data rather than the 7 days the links provide. While Afrezza seems to have mild interest, overall interest in "inhaled insulin" is on the decline. More interesting are the state by state comparisons of the two charts; it would seems that the area with the most interest in inhaled insulin (Mass, NY and Penn) are less interested in Afrezza (comparatively speaking) while California is about the same.
Likewise, there are a bunch of states where people are searching for Afrezza but not at all on inhaled insulin. It is certainly evident which states the company is targeting and which they have chosen to ignore.
|
|
|
|
Post by awesomo on Jan 17, 2019 12:07:47 GMT -5
Seven days is way too short of a sample to gauge anything. Move the timeframe to even a month or a year and there is no upwards trend.
|
|
|
|
Post by #NoMoreNeedles on Jan 17, 2019 12:26:05 GMT -5
I wonder what the data would look like removing all the MNKD shareholders doing searches!
|
|
|
|
Post by stevil on Jan 17, 2019 15:44:48 GMT -5
That's really funny. My state is very well represented. I'm going to go ahead and pat myself on the back and pretend I'm having a profound impact.
|
|
|
|
Post by akemp3000 on Jan 17, 2019 15:53:22 GMT -5
The new DTC TV ad campaign only began Monday. It will be most interesting to see a trend graph a month from now as viewers begin to see the same commercial a second, third and fourth time.
|
|
|
|
Post by itellthefuture777 on Jan 17, 2019 16:00:17 GMT -5
Script count tomorrow or next week should be really great imo..also..Mannkind doesnt have to limit to 1000..they can expand it to 65k..depending on demand forces..imo |
|
|
|
Post by sportsrancho on Jan 17, 2019 16:05:59 GMT -5
Wouldn’t it make sense that inhaled insulin is on the decline and Afrezza is on the way up because people have learned the name of the inhaled insulin?
|
|
|
|
Post by InvesterSam on Jan 17, 2019 18:07:01 GMT -5
Wouldn’t it make sense that inhaled insulin is on the decline and Afrezza is on the way up because people have learned the name of the inhaled insulin? Right on! You are a smart lady. I am watching your posted number and wondering when it will reach 10,000. I have a feeling that something good will happen by then.  |
|
|
|
Post by parrerob on Jan 18, 2019 4:15:14 GMT -5
Disappointed
Googling: "non injectable medications for diabetes" no results about Afrezza. There are alse pre-built Q&A and Afrezza is never included in the answers.
There is one Q&A: "is there an alternative to insuline injection ?"
opening the answer the sentence is: "In short, they don't play well in the sand box with other meds, while insulin plays well with other drugs. So in my book, while there are pills that can be substituted for insulin, there's really just no substitute for insulin"
That's correct but it is not the answer to the question. Seems that google doesn't know that exists inhable insuline....
But then if You google: "inhalable insuline" the first result is afrezza.com
Google connect the dots, please
|
|
|
|
Post by hellodolly on Jan 18, 2019 7:24:24 GMT -5
Love the approach $MNKD is taking rolling this out. I expect to see an increase in the search term "Afrezza" as more and more people learn the name.
|
|
|
|
Post by casualinvestor on Jan 18, 2019 12:33:40 GMT -5
Afrezza is on the second page when googling for "meal time insulin".
When searching for fast acting insulin, Afrezza is mentioned in article on the first page and second page, but Afrezza.com is nowhere to be found
Wikipedia is still the worst (from the insulin page):
In January 2008, the world's largest insulin manufacturer, Novo Nordisk, also announced that the company was discontinuing all further development of the company's own version of inhalable insulin, known as the AERx iDMS inhaled insulin system.[69] Similarly, Eli Lilly and Company ended its efforts to develop its inhaled Air Insulin in March 2008.[70] However, MannKind Corp. (majority owner, Alfred E. Mann) remains optimistic about the concept.[71]
Damn, that's old
|
|
|
|
Post by #NoMoreNeedles on Jan 18, 2019 12:36:24 GMT -5
Well, someone is getting paid the big bucks and has zero clue about search engine optimization (SEO).
|
|
|
|
Post by awesomo on Jan 18, 2019 13:00:24 GMT -5
Disappointed Googling: "non injectable medications for diabetes" no results about Afrezza. There are alse pre-built Q&A and Afrezza is never included in the answers. There is one Q&A: "is there an alternative to insuline injection ?" opening the answer the sentence is: "In short, they don't play well in the sand box with other meds, while insulin plays well with other drugs. So in my book, while there are pills that can be substituted for insulin, there's really just no substitute for insulin" That's correct but it is not the answer to the question. Seems that google doesn't know that exists inhable insuline.... But then if You google: "inhalable insuline" the first result is afrezza.com Google connect the dots, please It's not on Google to connect the dots, it is well known how their algorithms work and it is up to the company to "game the system". MannKind has abysmal SEO. |
|
|
|
Post by goyocafe on Jan 18, 2019 13:16:06 GMT -5
Disappointed Googling: "non injectable medications for diabetes" no results about Afrezza. There are alse pre-built Q&A and Afrezza is never included in the answers. There is one Q&A: "is there an alternative to insuline injection ?" opening the answer the sentence is: "In short, they don't play well in the sand box with other meds, while insulin plays well with other drugs. So in my book, while there are pills that can be substituted for insulin, there's really just no substitute for insulin" That's correct but it is not the answer to the question. Seems that google doesn't know that exists inhable insuline.... But then if You google: "inhalable insuline" the first result is afrezza.com Google connect the dots, please It's not on Google to connect the dots, it is well known how their algorithms work and it is up to the company to "game the system". MannKind has abysmal SEO. Worst case they could be using google adwords to display a banner ad on the first page of any keyword based search. There is no social media marketing taking place as far as I am concerned. Organic search results is a tough nut to crack, but as they've shown, they're willing to spend on TV ads, they could easily do the same for specific key words on the web. Oh well. |
|
